News | Oncomark

December 2019: OncoMasTR Clinical Validation Study Published in Peer-Reviewed Journal Clinical Cancer Research

Clinical Cancer Research Published a Key Study on the Clinical Validity of OncoMasTR Conducted by Researchers from The Institute of Cancer Research, Royal Marsden Hospital and Queen Mary University of London.

November 2019: OncoMark Founder Receives Award

OncoMark founder and Chief Scientific Officer Professor William Gallagher has been announced as winner of the prestigious 2019 Science Foundation Ireland (SFI) Entrepreneurship Award at the annual SFI Science Summit held in Athlone.

June 2019: OncoMark to present results from a key study at ASCO 2019

OncoMark to Present Key Study on OncoMasTR Test for Early Stage Breast Cancer at ASCO 2019 in Chicago

Presentation will highlight superior clinical performance of the OncoMasTR test in Irish patients enrolled in the TAILORx Trial

June 2018 - Results of Key Studies Announced

OncoMark Announces Results of Key Studies on Clinical Performance of Prognostic Test for Early Stage Breast Cancer

OncoMark Ltd, an Irish diagnostics company, today announced the results of two key studies on the clinical performance of its OncoMasTR test.